Association of biomarkers with atherosclerosis and risk for coronary artery disease in patients with HIV

Arquivos Brasileiros de Cardiologia

Volumn 99, Issue 5, 2012, Pages 971-978

  Falcão, Maria da Conceição Brandão de Arruda ^a   Zírpoli, Josefina Cláudia ^a   de Albuquerque, Valéria Maria ^b   Filho, Brivaldo Markman ^a   de Araújo, Nelson Antônio Moura ^a,b   Falcão, Creso Abreu ^b   Miranda Filho, Demócrito de Barros ^b   Ximenes, Ricardo Alencar de Arraes ^a,b   de Albuquerque, Maria de Fátima Militão ^c   Lacerda, Heloísa Ramos ^a,b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Atherosclerosis; Coronary disease; HIV; Risk factors

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOPINAVIR PLUS RITONAVIR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; FRAMINGHAM RISK SCORE; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NEPHELOMETRY; QUESTIONNAIRE; RISK; TRIACYLGLYCEROL;

ADULT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; BRAZIL; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; METABOLIC SYNDROME X; RISK FACTORS; SEX DISTRIBUTION;

EID: 84870462172     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2012005000093     Document Type: Article

References (27)

1. World Health Organization (WHO). Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS report on the global aids epidemic 2010. Geneva: UNAIDS 2010.[Accessed in 2011 June 18]. Available on http://www.unaids.org.
2. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de DST. Boletim Epidemiológico AIDS/DST.2010;7(1). Brasilia; 2010.
3. Marins JRP, Jamal LF, Chen SY, Barros MB, Hudes ES, Barbosa AA, et al. Dramatic improvement in survival among adult Brazilian AIDS patients. AIDS. 2003;17(11):1675-82.
4. D'Arminio MA, Sabin CA, Philllips A, Sterne J, May M, Justice A, et al. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med. 2005;165(4):416-23.
5. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patientes with Human Immunodeficiency Virus disease. J Clin Endocrinol Metab. 2007;92(7):2506-12.
6. Dubé M, Lipshultz SE, Fichtenbaum CJ, Greenberg R, Shecter AD, Fisher SD. Effects of HIV infection and retroviral therapy on the heart and vasculature. Circulation. 2008;118(2):36-40.
7. Palella FJ Jr, Phair JP. Cardiovascular diseaseinHIVinfection. Curr Opin HIV AIDS. 2011;6(4):266-71.
8. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356(17):1723-35.
9. Silva EFR, Bassichetto KC, Lewi DS. Perfil lipídico, fatores de risco cardiovascular e síndrome metabólica em um grupo de pacientes com AIDS. Arq Bras Cardiol. 2009;93(1):113-8.
10. Monteiro VS, Lacerda HR, Uellendah M, Chang TM, Albuquerque VM, Zirpoli JC, et al. Escore de cálcio na avaliação da aterosclerose em pacientes com HIV/AIDS. Arq Bras Cardiol. 2011;97(5):427-33.
11. Melendez MM, Mcnurlan MA, Mynarcik DC, Khan S, Gelato MC. Endothelial adhesion molecule are associated with inflammation in subjects with HIV disease. Clin Infect Dis. 2005;46(5):775-80.
12. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993;171(3):223-9.
13. Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost. 1994;72(1):151-4.
14. Hansson, GK. Inflammation, Atherosclerosis, and Coronary Artery Disease. N Engl J Med. 2005;352(16):1685-95.
15. Mochizuki K, Misaki Y, Miyavchi R, Takabe S, Shimada M, Miyoshi N, et al. Circulating interleukin-1β and interleukin-6 concentrations are closely associated with γ-glutamyltranspeptidase activity in middle-aged Japanese men without obvious cardiovascular disease. Metabolism. 2011;60(7):914-22.
16. Bennet AM, van Maarle MC, Hallqvist J, Morgenstern R, Frostegård J, Wiman B, et al. Association of TNF-α serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis. 2006;187(2):408-14.
17. Luc G, Arveiler D, Evans A, Amouyel P, Ferrieres J, Bard JM, et al. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incident coronary heart disease: the PRIME Study. Atherosclerosis. 2003;170(1):69-76.
18. Zakynthinos E, Pappa N. Inflammatory biomarkers in coronary artery disease. J Cardiol. 2009;53 (3):317-33.
19. Ross AC, Rizk N, O'Riordan MA, Droga V, EL Bejjani D, Storer N, et al. Relationship between Inflammatory Markers, Endothelial Activation Markers, and Carotid Intima-Media Thickness in HIV-Infected Patients Receiveing Antiretroviral Therapy. Clin Infect Dis. 2009; 49(7):1119-27.
20. Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, et al. Traditionalrisk factorsand D-dimerpredictincident cardiovascular disease events in chronic HIV infection. AIDS. 2010;24(10):1509-17.
21. Worm SW, Hsue P. Role of biomarkers in predicting CVD risk in the setting of HIV infection? Curr Opin HIV AIDS. 2010;5(6):467-72.
22. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499-511.
23. Baker JV, Duprez D. Biomarkers and HIV-associated cardiovascular disease. Curr Opin HIV AIDS. 2010; 5(6):511-16.
24. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr. 2009;51(3):268-73.
25. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Phamacol. 1995;25(2):9-12.
26. Mangili A, Polak JF, Quach LA, Gerrior J, Wanke CA. Markers of atherosclerosis and inflammation and mortality in patients with HIV infection. Atherosclerosis. 2011;214(2):468-73.
27. d'Ettorre G, Paiardini M, Ceccarelli G, Silvestri G, Vullo V. HIV-associated immuneactivation: from bench to bedside. AIDS Res Hum Retroviruses. 2011;27(4):355-64.